• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (SPARKS) BD BOTTLE BACTO PEPTONE 500G

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (SPARKS) BD BOTTLE BACTO PEPTONE 500G Back to Search Results
Catalog Number 211677
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/14/2021
Event Type  malfunction  
Manufacturer Narrative
A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that while testing with 4 bd bottle bacto peptone 500g there was atypical growth.The following information was provided by the initial reporter: it was reported that there is atypical growth.
 
Event Description
It was reported that while testing with 4 bd bottle bacto peptone 500g there was atypical growth.The following information was provided by the initial reporter: it was reported that there is atypical growth.
 
Manufacturer Narrative
H6: investigation summary this memo is to summarize findings on the complaint related to bottle bacto peptone 500g, catalog number 211677, batch 1123046, and complaint #3779516 for performance.Components are milled and blended (where required), and dispensed into containers.Following qc release, and based upon inventory demand, final packaging operations occur, which include dispensing into and labeling of final configurations, followed by transport to the distribution center.The complaint investigation included a review of the batch history record.The batch history record review indicated no discrepancies.All release testing was satisfactory.Release testing consists of powder appearance, solubility of 2 and 10% solutions, 2 and 10 % prepared solution appearance, residual solvents, ph, loss on drying, ash, nitrogen, amino nitrogen and growth promotion with organisms specified on the bd certificate of analysis.The complaint trends were reviewed for a period covering 12 months.During that time, there have been no other complaints on this product for performance defects.No returns or photos were received for the investigation.A retention sample from the complaint batch was tested for escherichia coli, atcc 25922 and staphylococcus aureus, atcc 25923 performance against a reference batch of bacto peptone.For performance testing, the peptone samples are combined with agar and salt to prepare an agar media per test instructions, then ph is adjusted as necessary.Samples are then boiled for one minute to dissolve, autoclaved at 121°c for 15 minutes then placed in a 45-50°c waterbath to cool.Upon cooling, plates are poured and allowed to solidify.Plates are streaked with cultures, 30-300 cfu per inoculum then incubated at 33-37°c for 42-48 hours.Satisfactory performance is good recovery.All samples were satisfactory; retention had comparable growth and colony size to the reference for both coa organisms.The uninoculated plates remained negative.Per the customer complaint intake, growth promotion issues are being observed with c.Albicans.The customer states that the organism should remain in the "yeast form" under normal conditions, but filamentation is observed with this organism when using lot 1123046 of material 211677.Bd does not maintain claims or performance data for this organism with bacto peptone.Consequently, this complaint cannot be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD BOTTLE BACTO PEPTONE 500G
Type of Device
NA
Manufacturer (Section D)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
katie swenson
9450 south state street
sandy, UT 84070
8015296192
MDR Report Key12800528
MDR Text Key281663558
Report Number1119779-2021-01806
Device Sequence Number1
Product Code PPM
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Distributor
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 11/17/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/11/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number211677
Device Lot Number1123046
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/17/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/03/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-